Spectrum Pharmaceuticals (SPPI)

11.56 -0.23  -1.99%  May 31, 3:20PM Go Pro
Watch this stock
View Full Chart SPPI Price Chart

Key Stats

Market Cap 684.86M
Revenue Growth 37.30%
Profit Margin 77.75%
Earnings Yield 11.42%
Dividend Yield 0.00%
Earnings Per Share TTM 1.32
PE Ratio 8.754
Price / Sales Ratio 3.273
52 Week High 16.00
52 Week Low 6.941
Beta 1.548
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

12:53 PM From those, I only hold $AMRN... lots of it, really. But I won't touch $SPPI unless I see $10.5 or lower. by mitrado
12:29 PM $AMRN, $SPPI, $KERX Any concerns about Friday Jobs report? Holding-selling-buying? http://stks.co/43Ed by JasonMilano8
8:57 AM $SPPI this could hit $13 after ASCO next week by johnkelly
2:32AM 4 Highly Liquid Biotech Stocks With Bearish Short Trends
May 30 The Many Reasons To Consider Spectrum Fool
May 29 @Bleedblue Loool. Basic english u r not understanding @Tarek307-how is ur day. Made 5times money today $AMRN. Tomorrow play $SPPI by SamRocks
May 29 @JasonMilano8 I was waiting for a dip in $SPPI, I got 50 shares of $SDRL instead. Nice dividend, while I'll keep waiting for $SPPI to dip. by mitrado
May 29 $AMRN will buy at $10.55, $KERX will buy at $1.66, $SPPI will buy at $10.75 by JasonMilano8
May 29 Out of $SPPI at $11.82, a 9.9% profit. by ANDISIK
May 29 $AMRN performs worst after a patent confirmation than $SPPI does, after starting a Phase 1 test!? Ridiculous. by mitrado
May 29 IsoRay: A Potential Small-Cap Bio-Pharma Multi-Bagger
May 29 Spectrum Pharmaceuticals (SPPI) Begins Enrollment n RenaZorb Phase 1 Street Insider
May 29 Spectrum Pharmaceuticals Announces Enrollment of First Group of Patients in Phase 1 C...

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Biotechnology

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Spectrum Pharmaceuticals is up 21.38% over the last year vs S&P 500 Total Return up 0.88%, Allos Therapeutics down 19.55%, and Cell Therapeutics down 43.47%.

  • SPPI Total Returns
  • ^SPXTR Total Returns
  • ALTH Total Returns
  • CTIC Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Balance Sheet View Statement

Get Quote for

Pro Strategies Featuring SPPI

Did Spectrum Pharmaceuticals make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

SPPI Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
SPPI 11.56 -0.23 -1.99% 698.79M
SPP 3.16 -0.13 -3.95% 1.646B
SPNS 3.90 -0.08 -2.01% 154.75M
SPN 21.63 +0.00 +0.00% 3.409B
SPMD 2.62 +0.02 +0.77% 40.22M
SPLS 13.24 -0.13 -0.97% 9.251B
SPIR 0.7502 -0.04 -5.04% 6.762M
SPIL 5.285 +0.01 +0.28% 3.264B
SPH 36.71 -0.27 -0.73% 1.313B
SPG 148.11 +1.93 +1.32% 43.53B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close